NF11_1_Par_TNO_1_hg38_rsem.cnt

syn63658738

Created By Alyza Skaist askaist

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

NF11_1_Par_TNO_1_hg38_rsem.cnt page is loading…